Dallas Voice (Dallas, Tex.), Vol. 28, No. 21, Ed. 1 Friday, October 7, 2011 Page: 41 of 68
sixty eight pages : ill.View a full description of this newspaper.
Extracted Text
The following text was automatically extracted from the image on this page using optical character recognition software:
• ketoconazole (Nizoral®}
• rifampin (Rifadin®, Rifamate®, Rifater®)
• Birth control pills. Birth control pills taken by mouth (oral contraceptives)
and other hormone types of birth control may not work to prevent
pregnancy. Talk with your doctor about other types of birth control that
you can use to prevent pregnancy during treatment with VIRAMUNE.
Also tell your doctor if you take:
• clarithromycin (Biaxin®}
• fluconazole (Diflucan®)
• indinavir sulfate (Crixivan®)
• methadone
• nelfinavir mesylate (Viracept®)
• rifabutin (Mycobutin®)
• warfarin (Coumadin®, Jantoven®)
• saquinavir mesylate (Invirase®)
If you are not sure if you take a medicine above, ask your doctor or
pharmacist.
Know the medicines you take. Keep a list of them to show your doctor or
pharmacist when you get a new medicine.
Kow should I take VIRAMUNE?
• VIRAMUNE is always taken in combination with other anti-HIV medications.
• Take VIRAMUNE exactly as your doctor tells you to take it. Oo not change
your dose unless your doctor tells you to.
• You should never take more than one form of VIRAMUNE at the same
time. Talk to your doctor if you have any questions.
• Do not crush or chew VIRAMUNE XR extended-release tablets.
• You may take VIRAMUNE with or without food.
• Do not miss a dose of VIRAMUNE, because this could make HIV harder
to treat. If you miss a dose of VIRAMUNE, take the missed dose as soon
as you remember. If it is almost time for your next dose, do not take the
missed dose, just take the next dose at your regular time. Do not take
two doses at the same time.
• If you stop taking VIRAMUNE for more than 7 days, ask your doctor how
much to take before you start taking it again. You may need to begin
taking the VIRAMUNE starting dose again, which is taken 1 time each
day for 14 days.
Starting VIRAMUNE tablets:
1. Your doctor should start you with 1 dose each day to lower your chance
of getting a serious rash. It is important that you only take 1 dose of
VIRAMUNE each day for the first 14 days.
• Call your doctor right away if you get a skin rash during the first
14 days of VIRAMUNE treatment and do not increase your dose to
2 times a day.
• You should never take your starting dose for longer than 28 days.
If after 28 days you are still receiving this starting dose because
you have a rash, you and your doctor should talk about prescribing
another HIV medicine for you instead of VIRAMUNE.
• Do not increase your dose to 2 times a day if you have a rash,
2. Day 15, you will take 1 VIRAMUNE tablet two times a day.
Starting VIRAMUNE XR extended-release tablets and this is the first
time you are taking any form of VIRAMUNE:
1, Your doctor should start you with 1 dose of VIRAMUNE tablets each day
to lower your chance of getting a serious rash It is important that you
only take 1 dose of VIRAMUNE each day for the first 14 days.
• Call your doctor right away if you get a skin rash during
the first 14 days of VIRAMUNE treatment and do not increase your
dose to 2 times a day,
• You should never take your starting dose for longer than 28 days.
If after 28 days you are still receiving this starting dose because
you have a rash, you and your doctor should talk about prescribing
another HIV medicine for you instead of VIRAMUNE.
• Do not start VIRAMUNE XR extended-release tablets if you have
a rash.
2. Day 15, you will take 1 VIRAMUNE XR extended-release tablet each day.
Switching from VIRAMUNE tablets to VIRAMUNE XR extended-release
tablets:
1. Take VIRAMUNE XR extended-release tablet 1 time a day.
If you take VIRAMUNE Oral Suspension:
• If you or your child takes VIRAMUNE suspension (liquid), shake it gently
before each use. Use an oral dosing syringe or dosing cup to measure
the right dose. The oral dosing syringe and dosing cup are not provided
with VIRAMUNE Suspension. Ask your pharmacist for a syringe or cup
if you do not have one.
• After drinking the medicine, fill the dosing cup with water and drink it to
make sure you get all the medicine.
• If the dose is less than 1 teaspoon (5 mL), use the syringe instead of
the dosing cup.
What are the possible side effects of VIRAMUNE?
VIRAMUNE may cause serious side effects, including:
• See "What is the most important information I should know about
VIRAMUNE?"
• Changes in your immune system (Immune Reconstitution
Syndrome) can happen when you start taking HIV medicines. Your
immune system may get stronger and begin to fight infections that
have been hidden in your body for a long time. Tell your doctor if you
start having new symptoms after starting your HIV medicine.
•Changes in body fat can happen in some people who take
antiretroviral therapy. These changes may include increased amount
of fat in the upper back and neck ("buffalo hump"), breast, and around
the middle of your body (trunk). Loss of fat from your legs, arms, and
face can also happen. The cause and long-term health effects of these
problems are not known at this time.
The most common side effect of VIRAMUNE is rash.
Tell your doctor if you have any side effect that bothers you or that does
not go away.
These are not all the possible side effects of VIRAMUNE. For more
information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side
effects to FDA at 1-800-FDA-1088.
How should I store VIRAMUNE?
• Store VIRAMUNE at 59°F to 86°F (15CC to 30°C).
• Throw away VIRAMUNE that is no longer needed or out-of-date.
Keep VIRAMUNE and all medicines out of the reach of children.
General information about VIRAMUNE.
Medicines are sometimes prescribed for purposes other than those listed
in a Medication Guide. Do not use VIRAMUNE for a condition for which it
was not prescribed. Do not give VIRAMUNE to other people, even if they
have the same condition you have. It may harm them.
This Medication Guide summarizes the most important information about
VIRAMUNE. If you would like more information, talk with your doctor. You
can ask your pharmacist or doctor for information about VIRAMUNE that is
written for health professionals.
For more information, go to www.viramune.com or www.viramunexr.com
or call Boehringer Ingeiheim Pharmaceuticals. Inc., at 1 -800-542-6257, or
(TTY) 1-800-459-9906.
What are the ingredients in VIRAMUNE?
Active ingredient; nevirapine
Inactive ingredients:
VIRAMUNE Tablets: microcrystalline cellulose, lactose monohydrate,
povidone, sodium starch glycolate, colloidal silicon dioxide, and
magnesium stearate
VIRAMUNE Oral Suspension; carbomer 934P, methylparaben, propylparaben,
sorbitol, sucrose, polysorbate 80, sodium hydroxide, and purified water
VIRAMUNE XR Tablets: lactose monohydrate, hypromellose, iron oxide,
and magnesium stearate
This Medication Guide has been approved by the U.S. Food and Drug
Administration
Distributed by: Boehringer Ingeiheim Pharmaceuticals, Inc.
Ridge-field, CT 06877 USA
Revised: May 2011
The brands listed are trademarks of their respective owners and are not trademarks of
Boehringer Ingeiheim Pharmaceuticals, Inc. Hie makers of these brands are not affiliated with
and do not endorse Boehringer Ingeiheim Pharmaceuticals, Inc., or its products.
Copyright 2011 Boehringer Ingeiheim Pharmaceuticals, inc.
ALL RIGHTS RESERVED
VXR-CBS-7/11 VXR1C100CONS
10.07.11
dallasvoice 41
Upcoming Pages
Here’s what’s next.
Search Inside
This issue can be searched. Note: Results may vary based on the legibility of text within the document.
Tools / Downloads
Get a copy of this page or view the extracted text.
Citing and Sharing
Basic information for referencing this web page. We also provide extended guidance on usage rights, references, copying or embedding.
Reference the current page of this Newspaper.
Nash, Tammye. Dallas Voice (Dallas, Tex.), Vol. 28, No. 21, Ed. 1 Friday, October 7, 2011, newspaper, October 7, 2011; Dallas, Texas. (https://digital.library.unt.edu/ark:/67531/metapth239188/m1/41/?rotate=90: accessed April 19, 2024), University of North Texas Libraries, UNT Digital Library, https://digital.library.unt.edu; crediting UNT Libraries Special Collections.